Senior Manager/Associate Director, Quality Control

Xenon Pharmaceuticals

Vancouver

Hybrid

CAD 214,000 - 272,000

Full time

14 days+

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

Xenon Pharmaceuticals seeks an experienced Senior Manager/Associate Director, Quality Control to lead QC activities supporting clinical and commercial drug substance (DS) and drug product (DP) programs in line with ICH and cGMP.

The role spans early to late clinical phases through registration, PPQ, and commercialization, with focus on analytical testing, stability, reference standards, investigations, and QC oversight.

Qualifications

  • The ideal candidate will have a strong background in small molecules, with experience spanning early to late clinical phases through registration, PPQ, and commercial stages.
  • Role requires expertise in analytical testing, specifications, stability program, reference standards, investigations, and quality control oversight across DS and DP manufacturing and testing campaigns.
  • Candidate should be collaborative, science- and data-driven, and thrive in a fast-paced environment.

Responsibilities

  • Review, manage all analytical/non-analytical results for product release, and stability, including OOS and OOT observations.
  • Lead stability activities, including trending, statistical evaluation, and interpretation of data to assess product performance and expiry dating justifications.
  • Manage reference standard program at external labs, including qualification and distribution to facilities.
  • Manage master specifications for starting materials, reference standards, API, and drug products.
  • Manage stability studies for reference standards, API, and drug products and monitor shelf-life data.
  • Lead investigations and draft reports for OOS/OOT results during release and stability testing.
  • Manage review/approval workflow for feasibility/comparability studies, validation protocols, reports, and test methods.
  • Lead QC checks on CMC sections of regulatory submissions (INDs, CTAs, NDAs).
  • Collaborate with QA to manage internal release documents for drug substances, drug products, and reference standards.

Job description

Xenon Pharmaceuticals ( NASDAQ:XENE ) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.

Who We Are:

Xenon Pharmaceuticals ( NASDAQ:XENE ) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.

What We Do:

We are advancing an exciting product pipeline to address indications with high unmet medical need, including epilepsy, depression and pain. Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we anticipate submitting a New Drug Application to the Food and Drug Administration in the third quarter of 2026. Our Phase 3 epilepsy program also includes a second FOS study, X-TOLE3, which would support regulatory submissions outside the U.S., and the X-ACKT study in primary generalized tonic‑clonic seizures, which would support regulatory submissions for an additional epilepsy indication. We also have multiple Phase 3 azetukalner clinical trials underway in major depressive disorder (MDD) and bipolar depression (BPD), based on topline data from our Phase 2 X-NOVA clinical trial. In addition, we are proud of our strong heritage in human genetics, deep understanding of ion channel biology, and expertise in novel chemistries to enable potent, selective ion channel targeting. We continue to advance an early‑stage pipeline of novel therapeutic candidates, including Phase 1 studies for XEN1701 and XEN1720 (targeting Nav1.7) and XEN1120 (targeting Kv7), which are being developed for pain. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.

About the Role:

We are seeking an experienced Senior Manager/Associate Director, Quality Control to lead Quality Control activities supporting clinical and commercial drug substance (DS) and drug product (DP) programs in accordance with ICH and cGMP requirements. The ideal candidate will have a strong background in small molecules, with experience spanning early to late clinical phases through registration, PPQ, and commercial stages. This role requires expertise in managing analytical testing, specifications, stability program, reference standards, investigations, and quality control oversight across DS and DP manufacturing and testing campaigns. The ideal candidate will be collaborative, science and data driven, and thrive working in a fast-paced environment.

This position reports to the Director, Quality Control and will be based out of either Vancouver, BC, Canada or Boston, MA, USA in our Needham office. The level of the position will be commensurate with the candidate's education and industry experience. Hybrid positions require a minimum of two onsite days per week. On-site positions require up to five on-site days per week.

RESPONSIBILITIES:
  • Review, manage all analytical/non-analytical results for product release, and stability, including OOS and OOT observations. Organize and file internal and external quality control data, protocols, and reports.
  • Lead the assigned program's stability activities, including trending, statistical evaluation, and scientific interpretation of stability data to assess product performance throughout its lifecycle, support shelf‑life extensions and expiry dating justifications, and proactively identify and evaluate emerging stability risks and trends.
  • Manage the reference standard program for the assigned clinical/commercial program at dedicated external labs, including qualification and distribution of reference standards to all manufacturing & testing facilities.
  • Manage master specifications for starting materials, reference standards, API, and drug products for assigned clinical/commercial program(s).
  • Manage stability studies for reference standards, API, and drug products for assigned programs. Compile stability protocols and monitor all stability data, including shelf‑life trending and extensions.
  • Lead investigations and draft reports for out-of-specification (OOS) and out-of-trend (OOT) results during release and stability testing in close collaboration with internal teams and external testing labs.
  • Manage the review and approval workflow for feasibility/comparability studies, validation protocols, reports, and test methods with internal experts and external partners.
  • Lead quality control checks on the CMC sections of regulatory submissions (e.g., Investigational New Drugs (INDs), Clinical Trial Applications (CTAs), and New Drug Applications (NDAs).
  • In collaboration with QA, manage internal release documents for drug substances, drug products, and reference standards
Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Senior Manager/Associate Director, Quality Control
Senior Manager/Associate Director, Quality Control

Xenon Pharmaceuticals Inc. • Vancouver

Hybrid
CAD 114,000 - 179,000
Manager/Senior Manager, GMP and GLP Outsourcing (Contract)
Manager/Senior Manager, GMP and GLP Outsourcing (Contract)

Xenon Pharmaceuticals • Vancouver

Hybrid
CAD 120,000 - 190,000
Manager/Senior Manager, GMP and GLP Outsourcing (Contract)
Manager/Senior Manager, GMP and GLP Outsourcing (Contract)

Xenon Pharmaceuticals Inc. • Burnaby

Hybrid
CAD 90,000 - 140,000
Stock options
Health benefits (medical, dental,视视)
Tuition assistance
+2
Manager/Senior Manager, GMP and GLP Outsourcing (Contract)
Manager/Senior Manager, GMP and GLP Outsourcing (Contract)

Xenon Pharmaceuticals Inc. • Vancouver

Hybrid
CAD 120,000 - 150,000
Manager, Quality Assurance
Manager, Quality Assurance

Value Apothecaries • Canada

On-site
CAD 110,000 - 150,000
Specialist, QC Technology Transfer
Specialist, QC Technology Transfer

Apotex Inc. • Toronto

On-site
CAD 84,000 - 140,000
Bonus programs
Pension plan
Benefits package
+1
Associate, Chemistry & Compendia RD7
Associate, Chemistry & Compendia RD7

Apotex Inc. • Toronto

On-site
CAD 63,000 - 106,000
Total Rewards package
Bonus programs
Comprehensive benefits
+2
Senior Manager/Associate Director, QA Operations
Senior Manager/Associate Director, QA Operations

AbCellera • Vancouver

On-site
CAD 124,000 - 155,000
Equity
Annual bonus
RRSP contribution
+3
Chemist, AD RD7
Chemist, AD RD7

Apotex Inc. • Richmond Hill

On-site
CAD 63,000 - 106,000
Mgr/Sr Regulatory CMC Consultant - Small Molecule & Veeva RIM Must Have
Mgr/Sr Regulatory CMC Consultant - Small Molecule & Veeva RIM Must Have

Syneos Health, Inc. • Canada

Remote
CAD 56,000 - 115,000
Health benefits
Company car or car allowance
Paid time off